Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

SynOx Therapeutics’ €37m Series A Led by HealthCap & Medicxi (2020-11-19)
> Financing to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumours SynOx Therapeutics Ltd ("SynOx"), a clinical stage biopharmaceutical company, announces today the closing of a €37 million Series A financing co-led by Hea...
Rebus Biosystems’ $20m Series B Led by Illumina Ventures (2020-11-19)
> Early access service available now; standalone instrument launching early 2021 > Rebus Biosystems is the new name for Optical Biosystems Rebus Biosystems, Inc., a life science technology company building innovative tools to enable spatial omics without co...
SR One: Spin-out from GSK & Close of First Fund at $500m (2020-11-19)
> Largest first-time venture capital fund to close in 2020 focused on US/EU biotech > Simeon George, M.D., Chief Executive Officer, leads an investment team with more than a decade of investment success > Trans-Atlantic footprint with additions to European ...
Umoja Biopharma Launches with $53M Series A Financing (2020-11-18)
> Umoja’s platform addresses key limitations of existing engineered immunotherapies > Company backed by prominent life science investors MPM Capital, DCVC Bio and Qiming Venture Partners USA and led by an experienced team of scientist/entrepreneurs. Umoja ...
Pharvaris Closes $80m Series C Financing Round (2020-11-18)
> New investors include Viking Global Investors, General Atlantic, and Cormorant Asset Management, with an expanded position by Venrock Healthcare Capital Partners > Phase 2 study of PHVS416 expected to initiate in 2021 Pharvaris, a clinical-stage company f...
ATP Launches Nereid Therapeutics with $50m Series A (2020-11-16)
Apple Tree Partners (ATP), a leading life sciences venture firm, today announced the launch of Nereid Therapeutics, a company dedicated to discovering new disease treatments by applying pioneering research and technologies in biomolecular condensates. ATP created N...
64x Bio Emerges from Stealth & Discloses $4.5m Seed Round (2020-11-16)
64x Bio announced today that they are emerging from stealth and are describing for the first time their proprietary VectorSelect™ platform and vision for the company. The company is a spinout of Harvard’s Wyss Institute and has developed breakthrough cellular scree...
Sanofi Invests €50m in Jeito Capital (2020-11-13)
Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated to biotech and biopharma, today announced that Sanofi has made a €50 million investment in Jeito Capital. The investment will be deployed by Jeito’s highly experienced team of pharmaceutical...
BRAND NEW – the [LSE] Newsletter Is Out! (2020-11-12)
You can read the latest version of the [LSE] Newsletter online at https://www.life-sciences-europe.com/newsletter/lse-newsletter-021011-aaaz.html...
UCB Expands in Gene Therapy: Acquisition & Collaboration (2020-11-12)
> Acquisition of Handl Therapeutics BV augments UCB’s existing early gene therapy pipeline with two research programs, a proprietary adeno-associated virus (AAV) capsid technology platform and capabilities > New R&D collaboration with Lacerta Therapeutics provi...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]